This bill establishes regulations regarding the use of di(2-ethylhexyl) phthalate (DEHP) and other ortho-phthalates in medical equipment, specifically intravenous solution containers and tubing. The legislation recognizes the toxic nature of DEHP, which is commonly used as a plasticizer in medical devices, and its potential health risks, including endocrine disruption and links to certain cancers. Starting January 1, 2028, the bill prohibits the manufacture, sale, or distribution of intravenous solution containers containing intentionally or unintentionally added DEHP in quantities exceeding 0.1 percent. A similar prohibition for intravenous tubing will take effect on January 1, 2035.

Additionally, the bill defines key terms related to DEHP and outlines exemptions for specific medical items, such as human blood collection bags and apheresis kits, as per existing federal regulations. It also clarifies that the Department of Ecology retains authority over DEHP and other ortho-phthalates under existing law. The bill includes a severability clause to ensure that if any part of the act is deemed invalid, the remaining provisions will still be enforceable.